497 related articles for article (PubMed ID: 27840903)
21. Arsenic trioxide-induced death of neuroblastoma cells involves activation of Bax and does not require p53.
Karlsson J; Øra I; Pörn-Ares I; Påhlman S
Clin Cancer Res; 2004 May; 10(9):3179-88. PubMed ID: 15131059
[TBL] [Abstract][Full Text] [Related]
22. Investigation of the mechanism involved in the As2O3-regulated decrease in MDR1 expression in leukemia cells.
Gao F; Liu J; Dong WW; Wang W; Wang Y; Cai D; Zheng Z; Sun K
Oncol Rep; 2014 Feb; 31(2):926-32. PubMed ID: 24337533
[TBL] [Abstract][Full Text] [Related]
23. Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.
Zhou C; Boggess JF; Bae-Jump V; Gehrig PA
Gynecol Oncol; 2007 Apr; 105(1):218-22. PubMed ID: 17275888
[TBL] [Abstract][Full Text] [Related]
24. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
25. Anti-apoptotic and apoptotic pathway analysis of arsenic trioxide‑induced apoptosis in human gastric cancer SGC-7901 cells.
Yu Y; Yang Y; Wang J
Oncol Rep; 2014 Sep; 32(3):973-8. PubMed ID: 24969414
[TBL] [Abstract][Full Text] [Related]
26. [Arsenic trioxide induced cell apoptosis by mitochondria dependent pathway in KB and KBv200 cells].
Li YF; Wang XD; Liang YJ; Chen LM; Ding Y; Huang M; Fu LW
Ai Zheng; 2004 Jun; 23(6):631-4. PubMed ID: 15191660
[TBL] [Abstract][Full Text] [Related]
27. Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma.
Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
J Natl Cancer Inst; 2004 Oct; 96(19):1457-66. PubMed ID: 15467035
[TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide in environmentally and clinically relevant concentrations interacts with calcium homeostasis and induces cell type specific cell death in tumor and non-tumor cells.
Florea AM; Büsselberg D
Toxicol Lett; 2008 Jun; 179(1):34-42. PubMed ID: 18485628
[TBL] [Abstract][Full Text] [Related]
29. Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons.
Vernhet L; Allain N; Le Vée M; Morel F; Guillouzo A; Fardel O
J Pharmacol Exp Ther; 2003 Jan; 304(1):145-55. PubMed ID: 12490585
[TBL] [Abstract][Full Text] [Related]
30. [Toxicity of arsenic trioxide to human lung adenocarcinoma cell line SPCA1 and its mechanism].
Wei L; Wang XW; Zuo WS
Ai Zheng; 2004 Dec; 23(12):1633-8. PubMed ID: 15601551
[TBL] [Abstract][Full Text] [Related]
31. Radiosensitizing effects of arsenic trioxide on MCF-7 human breast cancer cells exposed to 89 strontium chloride.
Liu H; Tao X; Ma F; Qiu J; Wu C; Wang M
Oncol Rep; 2012 Nov; 28(5):1894-902. PubMed ID: 22922982
[TBL] [Abstract][Full Text] [Related]
32. O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in SK-N-DZ neuroblastoma cells.
Cannizzaro A; Verga Falzacappa CV; Martinelli M; Misiti S; Brunetti E; Bucci B
J Cell Physiol; 2007 Oct; 213(1):115-25. PubMed ID: 17477375
[TBL] [Abstract][Full Text] [Related]
33. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
Cheng B; Yang X; An L; Gao B; Liu X
Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005
[TBL] [Abstract][Full Text] [Related]
34. Latent membrane protein-1 of Epstein - Barr virus increases sensitivity to arsenic trioxide-induced apoptosis in nasopharyngeal carcinoma cell.
Du CW; Wen BG; Li DR; Lin YC; Zheng YW; Chen L; Chen JY; Lin W; Wu MY
Exp Oncol; 2005 Dec; 27(4):267-72. PubMed ID: 16404345
[TBL] [Abstract][Full Text] [Related]
35. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
Seo T; Urasaki Y; Takemura H; Ueda T
Anticancer Res; 2005; 25(2A):991-8. PubMed ID: 15868938
[TBL] [Abstract][Full Text] [Related]
36. [Reversal effect and mechanism of arsenic trioxide on multidrug resistance of gastric carcinoma cells SGC7901].
Xue YW; Han JG; Li BX; Yang BF
Yao Xue Xue Bao; 2007 Sep; 42(9):949-53. PubMed ID: 18050736
[TBL] [Abstract][Full Text] [Related]
37. Pre-application of arsenic trioxide may potentiate cytotoxic effects of vinorelbine/docetaxel on neuroblastoma SK-N-SH cells.
Qi K; Li Y; Huang K; Xiong X; Chuchu F; Zhang C; Weng W
Biomed Pharmacother; 2019 May; 113():108665. PubMed ID: 30889490
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
[TBL] [Abstract][Full Text] [Related]
39. Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells.
Paffhausen T; Schwab M; Westermann F
Cancer Lett; 2007 May; 250(1):17-24. PubMed ID: 17141950
[TBL] [Abstract][Full Text] [Related]
40. [Apoptosis of MR2 cells induced by Tanshinone II A combined with arsenic trioxide].
Li L; Zhang ZH; Zhao WD
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):812-6. PubMed ID: 19950589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
